Letter to the Editor on Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid
We had the opportunity to read last issue’s article by Sharfman et al [1] regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject...
| Autores: | , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2016 |
| País: | Colombia |
| Recursos: | Universidad del Rosario |
| Repositório: | Repositorio EdocUR - U. Rosario |
| Idioma: | inglês |
| OAI Identifier: | oai:repository.urosario.edu.co:10336/26364 |
| Acesso em linha: | https://doi.org/10.1016/j.arth.2016.06.041 https://repository.urosario.edu.co/handle/10336/26364 |
| Access Level: | Acceso aberto |
| Palavra-chave: | Enoxaparin Tranexamic acid Anticoagulant agent Bleeding Blood donor Blood transfusion Chemoprophylaxis Drug efficacy Gold standard Human Intermittent pneumatic compression device Letter Practice guideline Preoperative period Thrombosis prevention Total hip prosthesis Total knee arthroplasty Venous thromboembolism Arthroplasty Knee replacement Anticoagulants replacement knee Hemorrhage Humans |
| Resumo: | We had the opportunity to read last issue’s article by Sharfman et al [1] regarding the use of an intermittent pneumatic compression device (IPCD) and tranexamic acid (TXA) as prophylactic measures against venous thromboembolic disease and bleeding, respectively. The authors’ research on the subject is a valuable contribution to the study of relevant perioperative complications after hip or knee arthroplasty, and their stepwise approach demonstrated interesting results in patient outcomes [1]. Nevertheless, we would like to contribute some observations that could lead to a better understanding of this article, especially regarding its main conclusion. The authors concluded and recommended that using an IPCD and TXA and discontinuing enoxaparin and preoperative autologous blood donation eliminated blood transfusion in hip or knee arthroplasty without any increase in venous thromboembolic disease [1]. However, this could bemisleading due to thelimitations of this study. |
|---|